Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)

2002431 citationsJournal Article

Authors

Atsushi Ohtsu · National Cancer Center Hospital East

Yasuhiro Shimada · National Cancer Center Hospital East

Kuniaki Shirao · National Cancer Center Hospital East

Narikazu Boku · National Cancer Center Hospital East

Ichinosuke Hyodo · National Cancer Center Hospital East

Hiroshi Saito · National Cancer Center Hospital East

Noboru Yamamichi

Abstract

Neither investigational regimen, FP nor UFTM, showed a survival advantage as compared with FU alone. FU alone will remain a reference arm in our future trial for advanced gastric cancer.

Topics & Keywords

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Gastrointestinal Tumor Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 21, Issue 1, pp. 54-59

DOI: 10.1200/jco.2003.04.130

Field-Weighted Citation Impact: 14.14